These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 21485125)
1. [Detection of glimepiride and rosiglitazone from Chinese dietary supplements]. Fujita Y; Honma H; Satoh J; Fujino Y; Onodera M; Inoue Y; Endo S Chudoku Kenkyu; 2011 Mar; 24(1):51-6. PubMed ID: 21485125 [TBL] [Abstract][Full Text] [Related]
2. Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening. Earle KE; Rushakoff RJ; Goldfine ID Diabetes Technol Ther; 2003; 5(3):449-51. PubMed ID: 12828829 [TBL] [Abstract][Full Text] [Related]
3. [A case of hypoglycemia caused by the accidental ingestion of glimepiride in an elderly dementia patient diagnosed based on the serum glimepiride concentration]. Fujieda N; Hazekawa I; Araki E Nihon Ronen Igakkai Zasshi; 2013; 50(4):550-4. PubMed ID: 24047673 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method. A K; G S; C MR; Bhat K; A R; P M; M S; K K; N U Pak J Pharm Sci; 2008 Oct; 21(4):421-5. PubMed ID: 18930865 [TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone/glimepiride (Avandaryl) for diabetes. Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189 [No Abstract] [Full Text] [Related]
6. Rosiglitazone + glimepiride: new drug. Another combination product to avoid. Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795 [No Abstract] [Full Text] [Related]
7. Simultaneous determination of anti-diabetes/anti-obesity drugs by LC/PDA, and targeted analysis of sibutramine analog in dietary supplements by LC/MS/MS. Kim SH; Lee J; Yoon T; Choi J; Choi D; Kim D; Kwon SW Biomed Chromatogr; 2009 Dec; 23(12):1259-65. PubMed ID: 19475544 [TBL] [Abstract][Full Text] [Related]
8. Octreotide for sulfonylurea-induced hypoglycemia following overdose. Carr R; Zed PJ Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568 [TBL] [Abstract][Full Text] [Related]
9. Hormonal counterregulation and consecutive glimepiride serum concentrations during severe hypoglycaemia associated with glimepiride therapy. Holstein A; Plaschke A; Hammer C; Ptak M; Kuhn J; Kratzsch C; Diekmann J; Kleesiek K; Maurer HH; Egberts EH Eur J Clin Pharmacol; 2003 Dec; 59(10):747-54. PubMed ID: 14634699 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Hypoglycemic Drugs by Liquid Chromatography-Tandem Mass Spectrometry. Jannetto PJ; Langman LJ Methods Mol Biol; 2024; 2737():297-306. PubMed ID: 38036831 [TBL] [Abstract][Full Text] [Related]
11. Increased frequency of micronuclei in diabetes mellitus patients using pioglitazone and glimepiride in combination. Nersesyan AK Food Chem Toxicol; 2011 Sep; 49(9):2470. PubMed ID: 21683753 [No Abstract] [Full Text] [Related]
12. A review of analytical techniques for determination of glimepiride: present and perspectives. Bonfilio R; de Araújo MB; Salgado HR Ther Drug Monit; 2010 Oct; 32(5):550-9. PubMed ID: 20736895 [TBL] [Abstract][Full Text] [Related]
13. Development of a rapid method for the determination of glimepiride in human plasma using liquid-liquid extraction based on 96-well format micro-tubes and liquid chromatography/tandem mass spectrometry. Dotsikas Y; Kousoulos C; Tsatsou G; Loukas YL Rapid Commun Mass Spectrom; 2005; 19(14):2055-61. PubMed ID: 15988714 [TBL] [Abstract][Full Text] [Related]
15. Absorbance detector for high performance liquid chromatography based on a deep-UV light-emitting diode at 235nm. da Silveira Petruci JF; Liebetanz MG; Cardoso AA; Hauser PC J Chromatogr A; 2017 Aug; 1512():143-146. PubMed ID: 28720223 [TBL] [Abstract][Full Text] [Related]
16. Results of a randomized, double-blind, placebo-controlled study administering glimepiride to patients with type 2 diabetes mellitus inadequately controlled with rosiglitazone monotherapy. McCluskey D; Touger MS; Melis R; Schleusener DS; McCluskey D Clin Ther; 2004 Nov; 26(11):1783-90. PubMed ID: 15639690 [TBL] [Abstract][Full Text] [Related]
17. Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia. Holstein A; Plaschke A; Hammer C; Egberts EH Eur J Clin Pharmacol; 2003 Jun; 59(2):91-7. PubMed ID: 12698302 [TBL] [Abstract][Full Text] [Related]
18. Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylurea. Thayer S; Arondekar B; Harley C; Darkow TE Ann Pharmacother; 2010 May; 44(5):791-9. PubMed ID: 20371759 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients. Rosenkranz B Horm Metab Res; 1996 Sep; 28(9):434-9. PubMed ID: 8911979 [TBL] [Abstract][Full Text] [Related]
20. [Persistent hyperinsulinemic hypoglycemia in newborn associated with glimepiride treatment at the beginning of pregnancy]. Balaguer Santamaría JA; Feliu Rovira A; Escribano Subias J; Salvadó Juncosa O; Sardá Auré P; Gussinyé Canadell M Rev Clin Esp; 2000 Jul; 200(7):399-400. PubMed ID: 10994361 [No Abstract] [Full Text] [Related] [Next] [New Search]